Approve a staged build of two complementary media engines.
Eighteen months. Premium historical originals and an acquisition first health network, supported by one shared digital rights, localization and monetization platform. Do not become only a lower cost production vendor, and do not attempt to recreate Little Dot Studios' full channel scale on day one. Own the high value upstream assets: formats, virtual worlds, production workflows and audience brands, while using selective distributors to accelerate reach.
The historical studio creates scarce, premium intellectual property. The health network creates publishing volume and recurring catalogue economics. Production services provide near term cash flow. The shared operating layer compounds data and distribution capability across both engines.
Verified external figures. Little Dot values are GBP and apply to Little Dot Studios Limited. Sources [1], [8] and [15].
An unusual starting position, engineered into a moat.
The company begins with two owned LED volumes, synthetic production expertise, a parent in natural health products, and the ability to treat each production as both a programme and a reusable asset system. That is a credible route to a vertically integrated factual media company built on three engines.
Premium History Studio
High value docudrama and production services. Earns fees, commissions, licences and retained IP.
- Formats and episodes
- Reusable virtual worlds
- Archive and brand
Health Media Network
Licenses, packages and monetizes completed programming through AVOD, FAST, sponsorship and commerce attribution.
- Audience and catalogue
- Data and relationships
- Channel brands
Shared Digital Platform
Runs channels, rights, localization, analytics and sales. Lowers marginal cost and adds third party service revenue.
- Operating data
- Workflows
- Distribution leverage
Why the combination is stronger
Compete with Little Dot where ownership matters; collaborate where its distribution scale creates more value than the rights surrendered.
YouTube reports 1B+ hours of daily viewing on TV screens. Nielsen measured 96% growth in TV based YouTube viewing among adults 65+ (Feb 2023 to Feb 2025). Omdia estimated 2025 global FAST ad revenue of US$5.7B, ~13% annual growth projected through 2030. Sources [8] to [10], [12].
Little Dot Studios: how a rights and audience company makes money.
The relevant benchmark, because it is not merely a producer. It is a multi platform production company, social agency, digital rights manager, owned media network, direct advertising business and subscription content owner. Founded 2013, launched its digital network in 2016, acquired WING and History Hit in 2020, and became wholly owned by All3Media in 2021.
Operating margin 18.6% · cash £16.34m · average employees 354. Operating profit up ~51% year over year, £5.0m dividends paid to parent. Source: Companies House 2024 filed accounts [1]. 2023 comparator is restated/unaudited; not a consolidated group valuation.
Little Dot generated this revenue on only ~£0.20m of net tangible fixed assets and ~£3.55m of intangibles. The core productive assets are rights, software, relationships, audience, data and know how, not expensive physical infrastructure. DramDoc begins with the opposite advantage, owned infrastructure, and must deliberately build the same intangible layer.
Little Dot reports 46M global subscribers, 200+ content providers and seven FAST brands across 130+ feeds; 680M average monthly ad impressions and 244M hours viewed monthly. Timeline alone had ~5.87M subscribers and 1.07B lifetime views in July 2026. Sources [3], [4], [7].
The shared rights and audience flywheel
Data lowers acquisition risk and improves each new commission.
What to emulate, and what not to copy
Emulate now
- Shared rights, publishing and analytics infrastructure
- Revenue share licensing and limited guarantees
- Multiple windows from one master
- Service work funding owned IP bets
- Data led acquisitions and commissions
Defer or avoid
- Launching dozens of channels before catalogue depth exists
- Large outright catalogue purchases without title level data
- Building proprietary SVOD technology too early
- Dependence on one platform or one distributor
- Giving away format, sequel and worldwide digital rights
Durable history demand, a television sized YouTube, and an aging audience.
Historical content shows durable global demand across SVOD, television, YouTube and FAST. Netflix reported ~58.5M viewing hours for the two season Rise of Empires: Ottoman franchise in 2023. Timeline's billion plus lifetime views prove premium broadcast history earns a second economic life on YouTube.
No reliable public budget has been disclosed for Rise of Empires: Ottoman. This plan deliberately excludes speculative production cost claims and treats DramDoc's cost advantage as a testable management hypothesis.
Little Dot's Autumn/Winter 2026 acquisition list explicitly seeks ancient and medieval history, historical reenactment, feudal Japan and China, global war, royalty, archaeology, mysteries, Vikings and Normans. That is direct buyer evidence for the subjects DramDoc is positioned to produce. Canada generated ~CAD $406M of documentary and ~CAD $472M of lifestyle/human interest production in 2024/25; British Columbia recorded ~CAD $3.56B of film and TV spending across 372 projects in 2024.
Channel roadmap: where to prove, where to wait
| Channel | Role | When to use |
|---|---|---|
| YouTube AVOD | Audience discovery, title testing, recurring ad revenue | Launch immediately |
| FAST | Scheduled connected TV viewing and extra ad inventory | After sufficient hours and demonstrated repeat viewing |
| SVOD / licensing | Premium window, minimum guarantees, institutional buyers | Per title negotiations from launch |
| Social short-form | Discovery and promotion | Derivative output from each long-form master |
| Owned email / community | Audience portability, lower platform dependence | Build from day one |
FAST is growing but crowded: Gracenote counted 303 entertainment category FAST channels in its 2025 analysis; Amagi reported entertainment as 42% of new launches. The implication is a sharply positioned brand, not another general documentary channel. Sources [8] to [11].
The health acquisition opportunity
Health video is not untouched. The whitespace is narrower: premium long form healthy aging and human body programming that combines documentary storytelling, transparent ownership, licensed clinical governance and platform native packaging.
| Archetype | Strength | Typical weakness | DramDoc response |
|---|---|---|---|
| Institutional health | Authority and clinical trust | Short, utilitarian, locally focused | Cinematic long form with formal medical review |
| Creator / podcast | Personality and frequency | Single expert dependence; limited catalogue rights | Multi title library and multiple experts |
| Broad doc aggregators | Volume and digital operations | Health is one category among many | Focused healthy aging brand and parent expertise |
| Health streaming networks | Vertical advertiser proposition | Often healthcare system or patient acquisition focused | Global consumer factual and lifestyle positioning |
| Supplement brands | Direct commerce | Low editorial independence and audience skepticism | Separate media governance and disclosed sponsorship |
Health Canada reports 71% of Canadians have used NHPs. Statistics Canada projects 65+ at ~21.3% to 22.9% of population by 2030. WHO projects 1.4B people aged 60+ globally by 2030. Market gap is management analysis, not a third party market size estimate. Sources [3], [15] to [18], [25].
Sell capability without surrendering the IP that creates value.
Premium History Studio
The flagship proposition is premium historical docudrama built from reusable virtual worlds, disciplined research and multiple deliverables from each shoot.
Production services
LED volume and synthetic production services for broadcasters, producers, museums and brands.
Commissioned history
Broadcaster or platform financed programmes produced at attractive margins.
Owned originals
Recurring formats where DramDoc retains copyright and downstream rights.
Virtual world licensing
Controlled access to reusable historical environments and assets.
Educational versions
Curriculum, exhibitions and immersive derivatives for museums and schools.
Build worlds, not sets
An Ottoman palace or wartime command room is a reusable IP asset across episodes, languages and customers. Development spend becomes a growing library.
For historically suitable projects, test a 35% to 50% reduction against conventional location heavy bids while maintaining market facing value. An internal target to validate through line by line comparative bids, not a verified industry statistic.
| Required delivery | Purpose |
|---|---|
| 45 to 52 minute broadcast master | Primary commission and licensing asset |
| Textless international master + M&E | Localization and international sales |
| Three to six thematic digital cuts | Search led YouTube programming |
| Short-form package | Discovery across social platforms |
| 90 minute / anthology compilation | Extended CTV and FAST viewing, where editorially valid |
| Clean stills, key art, metadata | Packaging, sales and rights administration |
Health Media Network
Remarkable stories and practical science about how human beings stay strong, mobile, capable and independent for longer.
An acquisition and distribution business first. License completed programming, package it for digital audiences, and use data to identify the subgenres worth commissioning. It operates under a separate consumer brand from both DramDoc and the supplement parent.
| Programming pillar | Examples | Acquisition posture |
|---|---|---|
| Human-body science | Sleep, brain, muscle, circulation, digestion, medical technology | Core; broadly exportable |
| Healthy aging | Mobility, strength, cognition, rehabilitation, community | Core; parent company adjacency |
| Medical stories | Hospitals, rare conditions, recovery, clinical teams | Selective; review graphic content |
| Healthy living | Movement, evidence led nutrition, cooking, stress | Selective; high claim review |
| Medical history | Discoveries, pioneers, evolution of care | Evergreen bridge to history expertise |
Content traffic light
Green
Anatomy, medical history, observational hospital, rehabilitation, mobility.
Amber
Nutrition, longevity, hormones, microbiome, mental health, weight loss.
Red
Miracle cures, anti vaccine content, unapproved treatments, conspiratorial medical claims.
Revenue architecture
| Revenue stream | History | Health | Control principle |
|---|---|---|---|
| Production services | Primary early cash flow | Selective institutional work | Price to market value, not internal cost |
| First-window licences | Broadcasters / streamers | Selective premium titles | Limit term, territory and platform |
| YouTube AVOD | Owned and partner channels | Primary proving ground | Retain title level reporting |
| FAST | Later catalogue window | After catalogue depth | Avoid premature technical spend |
| Sponsorship | Museums, travel, education | Health, fitness, lifestyle | Disclose commercial relationships |
| Commerce attribution | Limited | Parent and third party products | Count media fees, not total product sales |
| Rights management | Third party history catalogues | Third party health catalogues | Fee or transparent revenue share |
Learn the economics before owning the catalogue.
The first objective is not to own hundreds of hours. It is to learn the relationship between acquisition cost, packaging effort, audience response and long tail revenue. Begin with a diversified test slate and expand only around proven clusters.
Source 150 to 200 candidate hours from factual distributors and independent producers.
Medical screen and rights screen every title before commercial negotiation.
License 60 to 100 hours across 8 to 15 suppliers for the first cohort.
Publish two or three long form titles weekly, each with derivatives.
Review each title at 30, 90 and 180 days using contribution and audience data.
Renew and deepen only the highest performing subject and supplier combinations.
Preferred licence terms
| Term | Preferred opening position | Reason |
|---|---|---|
| Duration | 24 to 36 months | Health information and channel value can change quickly |
| Platforms | YouTube / AVOD; FAST option | Validate before paying for broad rights |
| Territory | English worldwide where available | Maximize scale while preserving seller flexibility |
| Exclusivity | Non exclusive or narrowly exclusive | Reduce minimum guarantees |
| Economics | Revenue share; modest MG for proven titles | Align incentives and preserve cash |
| Edit rights | Clips, compilations, intros, thumbnails, metadata | Required for platform native packaging |
| Medical withdrawal | Suspend / update right | Protect audience and platform standing |
| Chain of title | Full music, archive, talent, platform warranties | Reduce takedown and claims risk |
Historical rights doctrine
Every history agreement begins with a rights map, not a production budget. Know which rights create the downstream asset before accepting a commission.
Retain wherever possible
- Format and series bible
- Sequels and spin offs
- AVOD / FAST and education
- International masters
- Clip and compilation rights
Licence selectively
- First broadcast / SVOD window
- Defined territories
- Specific languages
- Fixed term
- Marketing excerpts
Do not transfer by default
- Reusable virtual environments
- Synthetic asset library
- Underlying research database
- Perpetual worldwide all media rights
- Unrestricted training use of assets
Use Little Dot, History Hit and other distributors as accelerators. Grant the smallest bundle of rights necessary to unlock the desired minimum guarantee, reach or sales capability.
Editorial and regulatory governance
A supplement owned health network faces an inherent trust conflict, manageable only through transparent ownership, real editorial controls and documented claim review.
| Control | Implementation |
|---|---|
| Transparent ownership | Publicly disclose ownership by the parent health company |
| Editorial independence | Editor in chief controls conclusions and corrections |
| Clinical oversight | Licensed medical director plus dietitian / pharmacist access |
| Evidence standard | Source log, publication date, review date, correction policy |
| Commercial separation | Parent is a disclosed advertiser, not the hidden editorial client |
| Claims register | Map product statements to approved Canadian NPN wording |
| Incident response | Immediate suspension, legal review, documented correction |
Health Canada requires ad claims consistent with the product label, monograph or licence. YouTube prohibits dangerous treatment and prevention misinformation, including in descriptions and outbound links. In the US, the FTC can treat third party articles and documentary material as advertising substantiation when used to sell a health product. Sources [18] to [21].
Four brands, one platform, a gated eighteen months.
| Brand layer | Audience facing promise | Relationship |
|---|---|---|
| DramDoc Studio | Premium cinematic history and factual production | Corporate / production master brand |
| History flagship | The past experienced as high stakes human drama | Owned original content brand |
| Health network | Science and stories for a longer, stronger life | Separate consumer brand, disclosed ownership |
| Parent health company | Products and health category expertise | Owner, capital provider, disclosed advertiser |
Channel launch cadence
| Output | First 6 months | After proof |
|---|---|---|
| Health long-form | 2 to 3 titles / week | 3 to 5 titles / week across focused feeds |
| Health shorts | 6 to 10 / week | Data led derivatives and sponsor inventory |
| History originals | One flagship proof + development slate | Two to three premium series annually |
| History digital | Proof film derivatives and licensed fillers | Consistent channel schedule |
| Localization | Test 2 languages on winners | Dedicated feeds after payback proof |
| FAST | No launch | Launch only with schedule depth and carriage path |
Incremental team
| Role | Timing | Core accountability |
|---|---|---|
| Head of Digital Rights & Network | Immediate | P&L, platform strategy, distributor relationships |
| Acquisitions & Rights Manager | Immediate | Sourcing, rights grid, contracts, renewals |
| Channel / Audience Lead | Immediate | Publishing, packaging, tests, channel health |
| Two packaging editors | 0 to 3 mo | Reversions, clips, compilations, QC |
| Data & Revenue Analyst | 3 to 6 mo | Title economics, dashboards, acquisition scoring |
| Health Editor / Standards Lead | Immediate | Editorial policy, sourcing, corrections |
| Licensed Medical Director | Fractional | Clinical review and governance |
| Business Affairs / Legal | Fractional | Chain of title, claims, privacy, platform terms |
| Direct Sales Lead | After proof | Sponsorship and network campaigns |
The eighteen month roadmap
No phase advances because the calendar elapsed. Health expansion requires title level payback evidence; history expansion requires buyer coverage, reusable asset proof and retained rights value; FAST requires catalogue depth and a credible carriage path.
A management planning case, not a forecast.
This is a management planning case, not an audited forecast or valuation. It excludes supplement product gross sales, unconfirmed tax credits, existing backlog and any undisclosed parent company resources.
| CAD millions | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| History services / commissions | 2.00 | 3.00 | 4.00 |
| Owned history licensing | 0.50 | 1.50 | 3.00 |
| Health AVOD / platform | 0.07 | 0.35 | 0.88 |
| Health sponsorship | 0.10 | 0.50 | 1.00 |
| Health commerce attribution | 0.05 | 0.30 | 0.80 |
| Health FAST / rights | 0.00 | 0.15 | 0.50 |
| Total revenue | 2.72 | 5.80 | 10.18 |
| Illustrative EBITDA | (0.08) | 0.80 | 2.38 |
| Illustrative EBITDA margin | (3%) | 14% | 23% |
What drives the outcome
| Sensitivity | Downside | Base | Upside |
|---|---|---|---|
| Year 3 health views | 125M | 250M | 400M |
| Net AVOD RPM | $2.50 | $3.50 | $4.50 |
| History first-window coverage | Low | Moderate | High |
| Direct sponsorship | Limited | Developing | Scaled |
| Result | Slower payback; preserve capital | Portfolio profitability | Accelerated channel and IP investment |
Illustrative 18 month deployment envelope
| Use | CAD | Purpose |
|---|---|---|
| History development & flagship proof | $800,000 | Concepts, research, proof film, reusable worlds |
| Health rights & minimum guarantees | $350,000 | 60 to 100 hour diversified test slate |
| Digital team & publishing | $550,000 | Rights, channels, packaging, analytics, operations |
| Medical editorial & legal | $200,000 | Clinical oversight, standards, claims, chain of title |
| Localization, data & launch marketing | $250,000 | Language tests, tools, audience development |
| Working capital & contingency | $350,000 | Timing, overruns, selective rights opportunities |
| Total | $2,500,000 | Stage gated; existing volume infrastructure excluded |
Financing levers: eligible Canadian owned productions may access the federal CPTC at 25% of qualified labour (capped near 15% of total cost). BC's basic Film Incentive BC credit is 40% of qualified BC labour for eligible Canadian content beginning principal photography on or after 1 Jan 2025. Production service structures may instead qualify for separate credits. Eligibility confirmed per production; not in the base case. Sources [22], [23].
Named risks, each with a designed control.
| Risk | Why it matters | Mitigation |
|---|---|---|
| Platform concentration | Algorithm or policy changes can impair revenue | Multiple windows; owned audience; title level profitability |
| Rights defects | Takedowns, claims and lost catalogue value | Rights grid, warranties, cue sheets, delivery QC |
| Health misinformation | Audience harm, enforcement, reputational loss | Clinical review, traffic light policy, corrections |
| Parent conflict | Supplement ownership can undermine trust | Disclosure, independent editor, separate commercial approvals |
| Content decay | Health recommendations can become obsolete | Shorter terms, review dates, suspension rights |
| Synthetic authenticity | Convincing reconstructions mistaken for fact | Provenance, disclosure, expert review |
| Production savings fail | Cost target may not survive talent, extras, complexity | Bid comparisons, pilot measurement, genre selection |
| Premature scale | Channels and FAST feeds add fixed cost before demand | One health brand first; stage gates; no early SVOD build |
| Cash timing | Rights, production and tax credits have different cycles | Working capital reserve and milestone financing |
The ask, and the seven moves that follow it.
Authorize the dual engine strategy and a 90 day design phase, with a second capital gate after the first health rights cohort and historical proof film package are contract ready.
Confirm the corporate and brand architecture, including transparent parent ownership of the health network.
Appoint the Head of Digital Rights & Network and a fractional medical director.
Commission three history concepts and one flagship proof film budget.
Open health acquisition conversations with at least 20 producers and distributors.
Build the rights database, medical review workflow and title contribution model.
Negotiate the first 60 to 100 hours using the preferred rights template.
Return to the board and parent with contracts, proof film bids and a refined 18 month operating budget.